OpenAI Expands Free ChatGPT Access to as Many as 200,000 Researchers, Doubling Its July Goal

OpenAI is expanding ChatGPT for Academic Researchers, offering 50,000 new grants toward a goal of 200,000 researchers worldwide, double its July target.

Share this article

Featured image: Gordon Hall at Harvard Medical School in Boston, in a September 2009 file photo. OpenAI said a researcher at Brigham and Women’s Hospital and Harvard Medical School is among participants in its academic program. The photo shows Gordon Hall, not the hospital and not a program event. Photo: EgorovaSvetlana, Wikimedia Commons, CC BY-SA 4.0. Cropped to 16:9.

OpenAI said Monday, Nov. 16, 2026, that it is expanding ChatGPT for Academic Researchers to give as many as 200,000 researchers worldwide free access to ChatGPT, double the goal it set when the pilot began in July. Applications for 50,000 new grants open Monday, Nov. 23, the company said, and will be awarded first come, first served.

Advertisement

Each grant covers the recipient and up to two collaborators at no charge, which OpenAI said can support up to 150,000 researchers in this round. The new grants will include ChatGPT Plus, not the Pro plan used in the summer pilot, after the company reviewed usage and found that most participants would have stayed within Plus limits. By default, OpenAI said, it does not use data shared through the program to train its models.

Already in the program
20,000
Researchers in 33 countries since July, OpenAI said
New grants
50,000
Applications open Nov. 23, first come, first served
This round, with collaborators
Up to 150,000
If every grant includes two collaborators
Program-wide goal
200,000
Double the July goal, OpenAI said

A Boston researcher is already in the pilot

In its announcement, OpenAI said 20,000 researchers in 33 countries have joined since the July pilot. Among the examples it named is Shuqi Li, a researcher at Brigham and Women’s Hospital and Harvard Medical School, who, the company said, looks for new drug targets that could shorten tuberculosis treatment and is exploring whether ChatGPT can help link laboratory and patient data to speed up antibiotic development. The company also cited Arthur Porto, assistant curator of AI biodiversity at the Florida Museum of Natural History, whose team, it said, uses AI tools to turn photographs of museum specimens into searchable databases.

Those are OpenAI’s descriptions of participants’ work, not independent accounts from the researchers or their institutions. The company did not publish a country-by-country table of the 20,000 people already in the program, beyond a map of waitlist signups as of Nov. 12. People already on the waitlist who qualify, it said, will get an email with activation instructions before applications open.

What the data shows

The new 200,000-person goal is, OpenAI said, “double the goal we announced when the pilot launched in July.” A Boston Report calculation from that statement puts the original July goal at 100,000 researchers. On the company’s own numbers, the 20,000 people who have already joined are 20% of that original goal and 10% of the new one. If every one of the 50,000 new grants is taken up and each includes two collaborators, this round would cover 150,000 people, or 75% of the 200,000 target — 7.5 times the current 20,000 participants. Those percentages are TBR calculations from OpenAI’s published totals. They treat the 50,000 grants as new and assume full uptake with two collaborators, which OpenAI described as a maximum, not a forecast.

Bar chart of OpenAI’s ChatGPT for Academic Researchers program scale: 20,000 current participants, a 100,000 July 2026 goal calculated from OpenAI’s double claim, 50,000 new grants, a 150,000 maximum this round, and a 200,000 program-wide goal
Source: OpenAI, “Broadening access to AI for scientists,” Nov. 16, 2026. The 100,000 July goal is a Boston Report calculation from OpenAI’s statement that 200,000 is double the original goal. Chart: The Boston Report.

OpenAI also published Science at the Frontier, a study by its Economic Research team of the summer pilot. The team analyzed 580,186 scientific messages from 1,819 scientists on the academic plan from Aug. 20 to Sept. 22, 2026, and surveyed 251 participants from Sept. 30 to Oct. 7. Surveyed scientists estimated that the same work, at the same quality, would have taken 1.9 times as long without AI — “nearly twice as long,” in the company’s shorter summary. Of 250 respondents asked about discovery timelines, 98% expected AI to accelerate discovery in their field. Sixty-eight percent of the 1,819 scientists used ChatGPT to develop research ideas, OpenAI said, and among ideation messages the company classified, 35% started from a scientist’s specific question, 36% refined an idea together, 23% asked ChatGPT to suggest a question, and 6% could not be categorized.

Those findings have limits that OpenAI itself stated. Productivity is self-reported, not a timed experiment. The 1.9-times figure averages eight research activities equally and includes 249 to 251 respondents per activity; when a scientist said they used no AI for an activity, the time was counted as unchanged. The discovery question asked people to imagine a finding that would take 10 years without AI and estimate how long it would take with it. “These findings do not establish causal effects,” the research team wrote. The team also said it used automated classifiers and did not read the underlying messages or ChatGPT’s responses.

Semafor reported the expansion the same day, including the 50,000 grants, the collaborator seats, and the doubling of the July target.

How the next round differs from the pilot

OpenAI said it is dropping lottery-based selection after feedback from the pilot. The next 50,000 grants will go to the first eligible applications. Switching new grants from ChatGPT Pro to Plus, it said, is meant to extend access to more research teams after the usage review. Participants will still get training on how to use ChatGPT in their research, the company said, and access to its frontier models.

Advertisement

The academic program is one of several research-access tracks OpenAI listed. Through ChatGPT Edu, it said, universities can give campus communities access for research, teaching and learning, with administrative controls. For biology labs, GPT-Rosalind and the Rosalind Academic Plan offer, the company said, up to 30 seats at no cost for up to 12 months at eligible U.S. universities, subject to a trusted-access approval process. OpenAI also said it contributed $5 million to a new Simons Foundation initiative to help mathematicians examine and build on results produced by AI.

The expansion is separate from OpenAI’s safety work announced the same day, in which the company signed four independent labs for embedded assessments. It is also separate from other large research efforts reported this month, including Apple’s 200,000-person U.S. study of how people use health AI and Google’s Gemini for Healthcare launch, which included a Massachusetts insurer among early users.

What OpenAI has not said

OpenAI did not publish the full eligibility rules in the main announcement, beyond saying grants go to eligible researchers and that waitlisted applicants who qualify will be contacted. It did not say how long the new Plus grants last, or how it will handle demand once 50,000 applications are in. The 200,000 figure is a program goal, not a count of people who already have access. Even if this round reaches its 150,000-person maximum, the company would still need further awards, or continued access for the 20,000 already enrolled, to get to 200,000, depending on how it counts overlapping or returning participants — details it did not spell out.

The study of the pilot describes how scientists used the tool and what they said they expect. It does not measure whether tuberculosis research, museum cataloging or other named projects actually moved faster. Those outcomes, if they are measured later, have not been published in the materials OpenAI released on Monday.

Sources

Read next in Artificial Intelligence

Get The Boston Report Briefing

Our free weekly email with the most important stories from Boston and the world. Unsubscribe anytime.

Free. We never sell your address. Privacy policy

Get The Boston Report Briefing
Our free weekly email with the most important stories from Boston and the world. Unsubscribe anytime.
Sign up